Kodiak Sciences Stock Price

1.28 (1.42%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 224,681
Bid Price 89.05
Ask Price 92.25
News -
Day High 92.25


52 Week Range


Day Low 86.78
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Kodiak Sciences Inc KOD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.28 1.42% 91.28 17:36:31
Open Price Low Price High Price Close Price Prev Close
90.09 86.78 92.25 91.28 90.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,956 224,681 $ 90.14 $ 20,253,440 - 73.19 - 171.21
Last Trade Time Type Quantity Stock Price Currency
17:39:10 63 $ 91.28 USD


Draw Mode:

Kodiak Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.72B 51.72M 21.27M $ - $ - -2.91 -19.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 154.53k 7.50%

more financials information »

Kodiak Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical KOD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week94.1294.6681.4386.48289,653-2.84-3.02%
1 Month116.29116.7881.4397.40252,214-25.01-21.51%
3 Months93.31131.9781.43104.55215,745-2.03-2.18%
6 Months81.96131.9776.3695.53242,4839.3211.37%
1 Year124.72171.2173.19109.10283,254-33.44-26.81%
3 Years10.00171.215.6571.43294,32381.28812.8%
5 Years10.00171.215.6569.94284,86381.28812.8%

Kodiak Sciences Description

Kodiak Sciences Inc is a clinical-stage company. It is engaged in developing innovative therapeutics to treat the high prevalence of ophthalmic diseases. The most advanced product candidate of the group is KSI-301, a biologic therapy built with an antibody biopolymer conjugate platform, which is designed to maintain potent and effective drug levels in ocular tissue.

Your Recent History
Kodiak Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.